Interestingly, overexpression of Ahi-1 alone in primitive hematopoietic cells confers a proliferative advantage in vitro and induces a lethal leukemia in vivo; these effects can be enhanced by BCR-ABL, a fusion oncoprotein that plays a major role in the genesis of CML [19]. Here, AHI1 is linked to leukemia.